MarketInsights

Data-driven market intelligence solutions

Published: September 2019 Latest Edition
1,245 Views

Global Ulcerative Colitis Drugs Market Forecast - Global Ulcerative Colitis Drugs Market Growth, Market Trends and Forecast

Life Sciences Pharmaceuticals Global Ulcerative Colitis Drugs Market Forecast - Global Ulcerative Colitis Drugs Market Growth Market Trends and Forecast

Report Description

Global Ulcerative Colitis Drugs Market Forecast - Global Ulcerative Colitis Drugs Market Growth, Market Trends and Forecast

Report Overview

Global Ulcerative Colitis Drugs Market Size and Overview



Ulcerative Colitis (UC) is a chronic, debilitating disease that affects large intestine or colon. Anti-inflammatory drugs or ulcerative colitis drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of medication includesulfasalazine (Azulfidine), mesalamine (Asacol HD, Delzicol, others), balsalazide (Colazal) and olsalazine (Dipentum).

Ulcerative colitis drugs market mainly driven by growing prevalence of ulcerative colitis diseases, increasing investment research and development by leading manufacturers towards development of novel therapies, and increasing focus of gove
ment and non-gove
ment organizations focus towards research in biologics. However, stringent gove
ment regulations towards approval of drugs could hamper the growth of this market to some extent.

The ulcerative colitis drugs market is segmented based on type, application, and geography. On the basis of type, ulcerative colitis drugs market divided into oral and injection. Further, the ulcerative colitis drugs market is segmented by application into hospital and drugs stores. Geographically, the ulcerative colitis drugs market is sub-divided into North America, Europe, Asia-Pacific, and Rest of the world.

The key market players operating in the ulcerative colitis drugs market include Johnson & Johnson, AbbVie, Takeda Pharmaceuticals, Roche, Wa
er Chilcott, Salix Pharmaceuticals/Santarus, Shire Pharmaceuticals, Ferring Pharmaceuticals, Pfizer, and InDeX Pharmaceuticals among others.

ULCERATIVE COLITIS DRUGS MARKET SEGMENTS

Market By Type

•    Oral

•    Injection

Market By Application

•    Hospital

•    Drugs Stores

Market By Geography

•    North America

•    Europe

•    Asia-Pacific

•    Rest of the world

Key Players

•    Johnson & Johnson.

•    AbbVie

•    Takeda Pharmaceuticals

•    Roche

•    Wa
er Chilcott

•    Salix Pharmaceuticals/Santarus

•    Shire Pharmaceuticals

•    Ferring Pharmaceuticals

•    Pfizer

•    InDeX Pharmaceuticals

Why Purchase This Report?

Market Intelligence

Comprehensive data on market size, growth rates, and segment analysis

Consumer Insights

Detailed analysis of purchasing behavior and preferences

Competitive Analysis

Profiles of key players and their market strategies

Future Trends

Emerging opportunities and market projections

Table of Contents

Executive Summary

1 Ulcerative Colitis Drugs Market Overview

    1.1 Product Overview and Scope of Ulcerative Colitis Drugs

    1.2 Ulcerative Colitis Drugs Segment by Type

        1.2.1 Global Ulcerative Colitis Drugs Production Growth Rate Comparison by Type (2014-2025)

        1.2.2 Oral

        1.2.3 Injection

    1.3 Ulcerative Colitis Drugs Segment by Application

        1.3.1 Ulcerative Colitis Drugs Consumption Comparison by Application (2014-2025)

        1.3.2 Hospital

        1.3.3 Drugs Stores

    1.4 Global Ulcerative Colitis Drugs Market by Region

        1.4.1 Global Ulcerative Colitis Drugs Market Size Region

        1.4.2 North America Status and Prospect (2014-2025)

        1.4.3 Europe Status and Prospect (2014-2025)

        1.4.4 China Status and Prospect (2014-2025)

        1.4.5 Japan Status and Prospect (2014-2025)

    1.5 Global Ulcerative Colitis Drugs Market Size

        1.5.1 Global Ulcerative Colitis Drugs Revenue (2014-2025)

        1.5.2 Global Ulcerative Colitis Drugs Production (2014-2025)


2 Global Ulcerative Colitis Drugs Market Competition by Manufacturers

    2.1 Global Ulcerative Colitis Drugs Production Market Share by Manufacturers (2014-2019)

    2.2 Global Ulcerative Colitis Drugs Revenue Share by Manufacturers (2014-2019)

    2.3 Global Ulcerative Colitis Drugs Average Price by Manufacturers (2014-2019)

    2.4 Manufacturers Ulcerative Colitis Drugs Production Sites, Area Served, Product Types

    2.5 Ulcerative Colitis Drugs Market Competitive Situation and Trends

        2.5.1 Ulcerative Colitis Drugs Market Concentration Rate

        2.5.2 Ulcerative Colitis Drugs Market Share of Top 3 and Top 5 Manufacturers

        2.5.3 Mergers & Acquisitions, Expansion

3 Global Ulcerative Colitis Drugs Production Market Share by Regions

    3.1 Global Ulcerative Colitis Drugs Production Market Share by Regions

    3.2 Global Ulcerative Colitis Drugs Revenue Market Share by Regions (2014-2019)

    3.3 Global Ulcerative Colitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

    3.4 North America Ulcerative Colitis Drugs Production

        3.4.1 North America Ulcerative Colitis Drugs Production Growth Rate (2014-2019)

        3.4.2 North America Ulcerative Colitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

    3.5 Europe Ulcerative Colitis Drugs Production

        3.5.1 Europe Ulcerative Colitis Drugs Production Growth Rate (2014-2019)

        3.5.2 Europe Ulcerative Colitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

    3.6 China Ulcerative Colitis Drugs Production (2014-2019)

        3.6.1 China Ulcerative Colitis Drugs Production Growth Rate (2014-2019)

        3.6.2 China Ulcerative Colitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

    3.7 Japan Ulcerative Colitis Drugs Production (2014-2019)

        3.7.1 Japan Ulcerative Colitis Drugs Production Growth Rate (2014-2019)

        3.7.2 Japan Ulcerative Colitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Ulcerative Colitis Drugs Consumption by Regions

    4.1 Global Ulcerative Colitis Drugs Consumption by Regions

    4.2 North America Ulcerative Colitis Drugs Consumption (2014-2019)

    4.3 Europe Ulcerative Colitis Drugs Consumption (2014-2019)

    4.4 China Ulcerative Colitis Drugs Consumption (2014-2019)

    4.5 Japan Ulcerative Colitis Drugs Consumption (2014-2019)

5 Global Ulcerative Colitis Drugs Production, Revenue, Price Trend by Type

    5.1 Global Ulcerative Colitis Drugs Production Market Share by Type (2014-2019)

    5.2 Global Ulcerative Colitis Drugs Revenue Market Share by Type (2014-2019)

    5.3 Global Ulcerative Colitis Drugs Price by Type (2014-2019)

    5.4 Global Ulcerative Colitis Drugs Production Growth by Type (2014-2019)

6 Global Ulcerative Colitis Drugs Market Analysis by Applications

    6.1 Global Ulcerative Colitis Drugs Consumption Market Share by Application (2014-2019)

    6.2 Global Ulcerative Colitis Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Ulcerative Colitis Drugs Business

    7.1 Johnson & Johnson.

        7.1.1 Johnson & Johnson. Ulcerative Colitis Drugs Production Sites and Area Served

        7.1.2 Ulcerative Colitis Drugs Product Introduction, Application and Specification

        7.1.3 Johnson & Johnson. Ulcerative Colitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

        7.1.4 Main Business and Markets Served

    7.2 AbbVie

        7.2.1 AbbVie Ulcerative Colitis Drugs Production Sites and Area Served

        7.2.2 Ulcerative Colitis Drugs Product Introduction, Application and Specification

        7.2.3 AbbVie Ulcerative Colitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

        7.2.4 Main Business and Markets Served

    7.3 Takeda Pharmaceuticals

        7.3.1 Takeda Pharmaceuticals Ulcerative Colitis Drugs Production Sites and Area Served

        7.3.2 Ulcerative Colitis Drugs Product Introduction, Application and Specification

        7.3.3 Takeda Pharmaceuticals Ulcerative Colitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

        7.3.4 Main Business and Markets Served

    7.4 Roche

        7.4.1 Roche Ulcerative Colitis Drugs Production Sites and Area Served

        7.4.2 Ulcerative Colitis Drugs Product Introduction, Application and Specification

        7.4.3 Roche Ulcerative Colitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

        7.4.4 Main Business and Markets Served

    7.5 Wa
er Chilcott

        7.5.1 Wa
er Chilcott Ulcerative Colitis Drugs Production Sites and Area Served

        7.5.2 Ulcerative Colitis Drugs Product Introduction, Application and Specification

        7.5.3 Wa
er Chilcott Ulcerative Colitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

        7.5.4 Main Business and Markets Served

    7.6 Salix Pharmaceuticals/Santarus

        7.6.1 Salix Pharmaceuticals/Santarus Ulcerative Colitis Drugs Production Sites and Area Served

        7.6.2 Ulcerative Colitis Drugs Product Introduction, Application and Specification

        7.6.3 Salix Pharmaceuticals/Santarus Ulcerative Colitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

        7.6.4 Main Business and Markets Served

    7.7 Shire Pharmaceuticals

        7.7.1 Shire Pharmaceuticals Ulcerative Colitis Drugs Production Sites and Area Served

        7.7.2 Ulcerative Colitis Drugs Product Introduction, Application and Specification

        7.7.3 Shire Pharmaceuticals Ulcerative Colitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

        7.7.4 Main Business and Markets Served

    7.8 Ferring Pharmaceuticals

        7.8.1 Ferring Pharmaceuticals Ulcerative Colitis Drugs Production Sites and Area Served

        7.8.2 Ulcerative Colitis Drugs Product Introduction, Application and Specification

        7.8.3 Ferring Pharmaceuticals Ulcerative Colitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

        7.8.4 Main Business and Markets Served

    7.9 Pfizer

        7.9.1 Pfizer Ulcerative Colitis Drugs Production Sites and Area Served

        7.9.2 Ulcerative Colitis Drugs Product Introduction, Application and Specification

        7.9.3 Pfizer Ulcerative Colitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

        7.9.4 Main Business and Markets Served

    7.10 InDeX Pharmaceuticals

        7.10.1 InDeX Pharmaceuticals Ulcerative Colitis Drugs Production Sites and Area Served

        7.10.2 Ulcerative Colitis Drugs Product Introduction, Application and Specification

        7.10.3 InDeX Pharmaceuticals Ulcerative Colitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

        7.10.4 Main Business and Markets Served

8 Ulcerative Colitis Drugs Manufacturing Cost Analysis

    8.1 Ulcerative Colitis Drugs Key Raw Materials Analysis

       8.1.1 Key Raw Materials

       8.1.2 Price Trend of Key Raw Materials

       8.1.3 Key Suppliers of Raw Materials

    8.2 Proportion of Manufacturing Cost Structure

    8.3 Manufacturing Process Analysis of Ulcerative Colitis Drugs

    8.4 Ulcerative Colitis Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

    9.1 Marketing Channel

        9.1.1 Direct Marketing

        9.1.2 Indirect Marketing

    9.2 Ulcerative Colitis Drugs Distributors List

    9.3 Ulcerative Colitis Drugs Customers

10 Market Dynamics

    10.1 Market Trends

    10.2 Opportunities

    10.3 Market Drivers

    10.4 Challenges

    10.5 Influence Factors

11 Global Ulcerative Colitis Drugs Market Forecast

    11.1 Global Ulcerative Colitis Drugs Production, Revenue Forecast

        11.1.1 Global Ulcerative Colitis Drugs Production Growth Rate Forecast (2019-2025)

        11.1.2 Global Ulcerative Colitis Drugs Revenue and Growth Rate Forecast (2019-2025)

        11.1.3 Global Ulcerative Colitis Drugs Price and Trend Forecast (2019-2025)

    11.2 Global Ulcerative Colitis Drugs Production Forecast by Regions (2019-2025)

        11.2.1 North America Ulcerative Colitis Drugs Production, Revenue Forecast (2019-2025)

        11.2.2 Europe Ulcerative Colitis Drugs Production, Revenue Forecast (2019-2025)

        11.2.3 China Ulcerative Colitis Drugs Production, Revenue Forecast (2019-2025)

        11.2.4 Japan Ulcerative Colitis Drugs Production, Revenue Forecast (2019-2025)

    11.3 Global Ulcerative Colitis Drugs Consumption Forecast by Regions (2019-2025)

        11.3.1 North America Ulcerative Colitis Drugs Consumption Forecast (2019-2025)

        11.3.2 Europe Ulcerative Colitis Drugs Consumption Forecast (2019-2025)

        11.3.3 China Ulcerative Colitis Drugs Consumption Forecast (2019-2025)

        11.3.4 Japan Ulcerative Colitis Drugs Consumption Forecast (2019-2025)

    11.4 Global Ulcerative Colitis Drugs Production, Revenue and Price Forecast by Type (2019-2025)

    11.5 Global Ulcerative Colitis Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

    13.1 Methodology/Research Approach

        13.1.1 Research Programs/Design

        13.1.2 Market Size Estimation

        13.1.3 Market Breakdown and Data Triangulation

    13.2 Data Source

        13.2.1 Secondary Sources

        13.2.2 Primary Sources

    13.3 Author List

    13.4 Disclaimer


Research Methodology

Our research methodology combines both primary and secondary research approaches to ensure data accuracy and reliability.

Primary Research

Industry Interviews

Conducted interviews with industry experts and key stakeholders

Consumer Surveys

Comprehensive surveys targeting relevant consumer segments

Secondary Research

  • Analysis of company annual reports, investor presentations, and regulatory filings
  • Review of industry publications, trade journals, and market studies
  • Government statistics and regulatory databases
  • Market data from reliable third-party sources

Frequently Asked Questions

Related Reports

Related Category Latest

Explore More Market Insights

Browse our complete catalog for related market research reports

View All Reports Multiple
Industry Popular

Custom Research Solutions

Need specific insights? Request a customized research report

Learn More Tailored

Purchase Options

Single User License

1 user access with no print restrictions

$4999

PDF

Five User License

Up to 5 users within your organization

$6399

Online/PDF

Enterprise License

Unlimited users within your organization

$5399

Online/PDF

Data Pack

Comprehensive data sets and analytics

$3999

Data Only

Need a custom solution?

Request Customization

Report Details

Published Date September 2019
Format PDF + Excel
Delivery Time Instant

Request Sample

Get a free sample before you buy

Download a free sample report to evaluate the quality and relevance of our research.

Download Sample (PDF)

Have Questions?

Get in touch with our analysts

Our team is ready to answer any questions you may have about this report.

Contact Us